Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 12,053 | 11,101 | 10,048 | 9,067 | 8,120 |
| Cost of Goods | 5,304 | 4,847 | 4,747 | 4,356 | 3,759 |
| Gross Profit | 6,749 | 6,254 | 5,301 | 4,711 | 4,361 |
| Operating Expenses | 13,941 | 14,281 | 14,420 | 13,307 | 13,716 |
| Operating Income | -6,888 | -7,180 | -8,372 | -8,240 | -8,596 |
| Interest Expense | 314 | 575 | 0 | -22 | 9 |
| Other Income | 0 | 0 | 35 | 0 | 0 |
| Pre-tax Income | -7,202 | -7,755 | -8,337 | -8,218 | -8,605 |
| Net Income Continuous | -7,202 | -7,755 | -8,337 | -8,218 | -8,605 |
| Net Income | $-7,202 | $-7,755 | $-8,337 | $-8,218 | $-8,605 |
| EPS Basic Total Ops | -0.12 | -0.14 | -0.15 | -0.15 | -0.16 |
| EPS Basic Continuous Ops | -0.12 | -0.14 | -0.15 | -0.15 | -0.16 |
| EPS Diluted Total Ops | -0.12 | -0.14 | -0.15 | -0.15 | -0.16 |
| EPS Diluted Continuous Ops | -0.12 | -0.14 | -0.15 | -0.15 | -0.16 |
| EBITDA(a) | $-6,336 | $-6,377 | $-8,138 | $-8,009 | $-8,368 |